Pakistan to India Pharmaceutical Import
Bilateral Trade Intelligence · $364 Total Trade · 1 Foreign Suppliers · 1 Indian Buyers · DGFT Verified · Updated March 2026
India imported $364 worth of pharmaceutical formulations from Pakistan across 10 verified shipments, from 1 foreign suppliers to 1 Indian buyers. The top suppliers are PFIZER LIMITED ($364). The leading products are Isoniazid ($130) and Rifampicin ($121). Average shipment value: $36.
Top Pharmaceutical Formulations — Pakistan to India
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Isoniazid | $130 | 35.6% |
| 2 | Rifampicin | $121 | 33.3% |
| 3 | Ethambutol | $113 | 31.1% |
India imports 3+ pharmaceutical formulations from Pakistan with a combined trade value of $364. Key products include Isoniazid ($130), Rifampicin ($121), Ethambutol ($113). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 10 verified Indian Customs (DGFT) shipment records.
Top Pharmaceutical Products — Pakistan to India Trade Routes
These are the top pharmaceutical products exported from India to Pakistan, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Pakistan buyers, regulatory requirements, and logistics for that specific product corridor. Products include Isoniazid ($130), Rifampicin ($121), Ethambutol ($113) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
Top Pakistan Suppliers to India
1 Indian pharmaceutical companies export finished formulations to Pakistan. Leading exporters include Pfizer Limited, . The top exporter accounts for 100.0% of total India–Pakistan pharma exports. Source: Indian Customs (DGFT).
Top Indian Buyers from Pakistan
1 companies in Pakistan import pharmaceutical formulations from India. Top buyers include Pfizer Healthcare India Private Limited, . The largest buyer accounts for 100.0% of India–Pakistan pharma imports. Source: Indian Customs (DGFT).
Trade Statistics
Other Import Origins
Product Routes
FAQ — India to Pakistan Pharmaceutical Trade
What is the total value of India's pharmaceutical export to Pakistan?
India exported pharmaceuticals worth $364 to Pakistan across 10 verified shipments.
Who are the top Indian pharmaceutical exporters to Pakistan?
1. PFIZER LIMITED — $364. Total: 1 suppliers.
Which companies in Pakistan import pharmaceuticals from India?
1. PFIZER HEALTHCARE INDIA PRIVATE LIMITED — $364. 1 buyers total.
What pharmaceutical products does India export most to Pakistan?
1. Isoniazid ($130, 35.6%); 2. Rifampicin ($121, 33.3%); 3. Ethambutol ($113, 31.1%)
Which ports handle pharmaceutical shipments from India to Pakistan?
Export: . Import: .
Why does Pakistan import pharmaceuticals from India?
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $364 corridor reflects quality compliance and pricing advantages.
What certifications do Indian pharmaceutical exporters need to supply Pakistan?
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
What is the average shipment value for India to Pakistan pharmaceutical trade?
$36 per consignment across 10 shipments.
How many Indian pharmaceutical companies export to Pakistan?
1 Indian companies. Largest: PFIZER LIMITED with $364.
How can I find verified Indian pharmaceutical suppliers for Pakistan?
TransData Nexus covers 1 active exporters with shipment history and trade values at transdatanexus.com.
Unlock the Full India to Pakistan Pharmaceutical Export Dataset
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 10 shipments.
Official References & Regulatory Resources
- WHO Essential Medicines List
- CDSCO India
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
- 2.Country Matching: Shipments to Pakistan identified using destination country codes from customs declarations.
- 3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
- 4.Coverage: 10 verified shipments from 1 Indian exporters to 1 Pakistan buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Exporters
1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists